Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects

Adv Healthc Mater. 2018 Jan;7(1). doi: 10.1002/adhm.201700886. Epub 2017 Sep 22.

Abstract

Drug and gene delivery systems based on nanoparticles, microparticles and hydrogels have been widely studied for cancer treatment in the past decade. To achieve an efficient and safe delivery, selection of drug and gene delivery carrier is critical. Biocompatible polymeric nanoparticles are considerably promising carrier candidates in delivery of drugs and genes because of their unique chemical and physical properties. However, delivery of a drug or gene sometimes cannot achieve a satisfactory treatment effect. Therefore, co-delivery of dual drugs or co-delivery of a drug and a gene in a polymeric nanoparticle has attracted attention. Such co-delivery systems can overcome multi-drug resistance of chemical drugs and achieve a synergistic therapeutic effect. In this progress report, we summarize recent progress in the preparation and application of polymeric drug and gene co-delivery nanosystems. The remaining challenges and future trends in this field are also included.

Keywords: cancer therapy; co-delivery; functional polymers; nanotechnology; synergistic effects.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Drug Delivery Systems / methods
  • Gene Transfer Techniques
  • Humans
  • Nanoparticles / chemistry*
  • Neoplasms / drug therapy*
  • Neoplasms / therapy
  • Polymers / chemistry*

Substances

  • Antineoplastic Agents
  • Polymers